NPR3 and cardiac hypertrophy: In another set of experiments using isoproterenol-induced in vivo model of HF, intramyocardial administration of an Npr3 siRNA reduced cardiac hypertrophy and fibrosis, and elevated the levels of circulating A-type natriuretic peptide [44].